Novast Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVAST LABS, and what generic and branded alternatives to NOVAST LABS drugs are available?
NOVAST LABS has eighty-eight approved drugs.
There are three tentative approvals on NOVAST LABS drugs.
Drugs and US Patents for Novast Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novast Labs | TRIAZOLAM | triazolam | TABLET;ORAL | 214219-002 | Oct 20, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novast Labs | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208783-005 | Jun 14, 2019 | AB3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novast Labs | PRAMIPEXOLE DIHYDROCHLORIDE | pramipexole dihydrochloride | TABLET, EXTENDED RELEASE;ORAL | 213444-004 | Feb 3, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novast Labs | DESOGESTREL AND ETHINYL ESTRADIOL | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 091234-001 | Jul 12, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novast Labs | CARBOPLATIN | carboplatin | INJECTABLE;INTRAVENOUS | 208487-001 | Apr 26, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novast Labs | TRIAZOLAM | triazolam | TABLET;ORAL | 214219-001 | Oct 20, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Novast Labs | CARISOPRODOL AND ASPIRIN | aspirin; carisoprodol | TABLET;ORAL | 040832-001 | Jan 7, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.